Paper 2021
Metformin Ameliorates the Severity of Experimental Alport Syndrome
Omachi K, Kaseda S, Yokota T, Kamura M, Teramoto K, Kuwazuru J, Kojima H, Nohara H, Koyama K, Ohtsuki S, Misumi S, Takeo T, Nakagata N, Li JD, Shuto T, Suico M.A., Miner J.H., Kai H.
Scientific Reports.2021 11:7053 doi:10.1038/s41598-021-86109-1
The role of discoidin domain receptor 2 in the renal dysfunction of Alport syndrome mouse model
Sannomiya Y, Kaseda S, Kamura M, Yamamoto H, Yamada H, Inamoto M, Kuwazuru J, Niino S, Shuto T, Suico M.A., Kai H.
Renal Failure.2021 Mar;43:1,510-519.doi:10.1080/0886022X.2021.1896548
Type IV Collagen Variants in CKD: Performance of Computational Predictions for Identifying Pathogenic Variants
Shulman C, Liang E, Kamura M, Udwan K, Yao T, Cattran D, Reich H, Hladunewich M, Pei Y, Savige J, Paterson A D., Suico MA, Kai H, Barua M.
Kidney Medicine.2021 Feb. doi:10.1016/j.xkme.2020.12.007
